Pyrrolocarbazoles as checkpoint 1 kinase inhibitors

被引:28
作者
Henon, Helene [1 ]
Conchon, Elisabeth [1 ]
Hugon, Bernadette [1 ]
Messaoudi, Samir [1 ]
Golsteyn, Roy M. [2 ]
Prudhomme, Michelle [1 ]
机构
[1] Univ Blaise Pascal, CNRS, Lab SEESIB, UMR 6504, F-63177 Aubiere, France
[2] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada
关键词
checkpoint kinase 1; antitumor agents; pyrrolocarbazole; granulatimide;
D O I
10.2174/187152008785133100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fused rings.
引用
收藏
页码:577 / 597
页数:21
相关论文
共 90 条
[61]   Checkpoint pathways come of age [J].
Nurse, P .
CELL, 1997, 91 (07) :865-867
[62]   4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1.: Structure-activity relationships for chromophore modification and phenyl ring substitution [J].
Palmer, Brian D. ;
Thompson, Andrew M. ;
Booth, R. John ;
Dobrusin, Ellen M. ;
Kraker, Alan J. ;
Lee, Ho H. ;
Lunney, Elizabeth A. ;
Mitchell, Lorna H. ;
Ortwine, Daniel F. ;
Smaill, Jeff B. ;
Swan, Leesa M. ;
Denny, William A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) :4896-4911
[63]  
PARRATT M, 2007, Patent No. 0179161
[64]  
PEVARELLO P, 2004, Patent No. 0235919
[65]   Improved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C [J].
Piers, E ;
Britton, R ;
Andersen, RJ .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (02) :530-535
[66]  
Prudhomme Michelle, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P435, DOI 10.2174/1568011043352795
[67]   p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage [J].
Reinhardt, H. Christian ;
Aslanian, Aaron S. ;
Lees, Jacqueline A. ;
Yaffe, Michael B. .
CANCER CELL, 2007, 11 (02) :175-189
[68]  
Roberge M, 1998, CANCER RES, V58, P5701
[69]   Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints [J].
Sancar, A ;
Lindsey-Boltz, LA ;
Ünsal-Kaçmaz, K ;
Linn, S .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :39-85
[70]   Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine [J].
Sharma, V ;
Tepe, JJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (16) :4319-4321